Midgard Science

Labs / CDMO: development & manufacturing

Polypeptide

San Diego, CA, United States · polypeptide.com

GMP

PolyPeptide is a CDMO focused on peptide-based therapies and peptide active pharmaceutical ingredients for pharmaceutical and biotech customers worldwide. It develops and manufactures proprietary and generic peptide APIs for applications including metabolic disease, cancer, cardiovascular, and neurological disorders. The company operates in Europe, the US, and India.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • GMP peptide manufacturing

    Manufactures GMP-grade peptides from initial gram quantities to commercial multi-kilogram or larger batches.

  • Pre-GMP development

    Develops robust production approaches, analytical characterization, and methods for lead peptides before GMP manufacture.

  • Production process development

    Develops small-scale to large-scale production processes for proprietary and generic peptides across development stages.

  • Quality assurance

    Reviews batch records and releases product in compliance with cGMPs through site and global QA units.

  • Quality control

    Provides analytical development, testing, and specifications to support API release and product life-cycle control.

  • GMP compliance and regulatory support

    Supports manufacturing in compliance with ICH Q7 and provides documentation for product approval from IND to NDA.

  • Commercial manufacturing

    Manufactures peptide products for commercial requirements and supports commercial production scale-up.

  • Custom R&D

    Supports custom peptide projects, including custom research-grade peptides.

  • Radiolabeled peptide manufacturing

    Produces radiolabeled peptides.

  • Generic peptide manufacturing

    Provides services for generic peptides.

What they work on

Modalities
Small molecule, Peptide
Species and models
pre-GMP animal toxicology lots, Phase I clinical trial material, Phase II clinical trial material, Phase III material
Assays and studies
analytical development, MS/MS sequencing, UHPLC, amino acid composition, chiral purity, bioburden testing, endotoxin testing, assay (peptide content), identity testing, moisture content, residual solvents testing
Instruments and platforms
UHPLC, MS/MS
Scale and capacity
initial gram quantities, multi-kilograms or more per batch, mg quantities, metric tons, 6 sites on 3 continents
Therapeutic areas
metabolic diseases, diabetes, obesity, cancer, cardiovascular disorders, neurological disorders
Turnaround
quick turnaround times
What to send
lead peptide designated for GMP manufacture · pilot lots · pre-GMP animal toxicology lots
Type
CDMO
Sites
Baar, Switzerland · Limhamn, Sweden · Strasbourg, France · Braine-l’Alleud, Belgium · Torrance, USA · San Diego, USA
Team
1,469 employees
Quality
ICH guidelines including Q7 · cGMP · other regulatory authorities inspections (facilities have been inspected by several other regulatory authorities)
Serves
North America, Europe, Asia, around the globe
Address
365 Maple Avenue Torrance CA 90503 USA
Founded
1952

Public records

Ownership
PolyPeptide Group AG · CH GLEIF
FDA establishment
1000519239
FDA drug establishment
Polypeptide Laboratories Inc source
Biocom California CRO directory
neoantigen, Peptides, small molecule source
FDA drug establishment registration
1000519239 · ANALYSIS; API MANUFACTURE source

Similar labs. DSK InnoSciences, RS Synthesis, ARSI Canada Inc, Aurigene Pharmaceutical Services

Found in the Biocom California CRO directory, a contract services directory. Listing built from polypeptide.com. Work here? Claim this listing.

Polypeptide · Midgard Science